Courtney Matthews
Family · Meadville, PANPI 1952153629
Payments from drug & device makers
Across 105 payments — averaging $24.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$302
- Incyte Corporation$209
- Novartis$182
- AbbVie$178
- Johnson & Johnson$169
- Regeneron Healthcare Solutions, Inc.$160
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,12482%
- Education$46418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $302 |
| Incyte Corporation | 6 | $209 |
| Novartis | 8 | $182 |
| AbbVie | 9 | $178 |
| Johnson & Johnson | 5 | $169 |
| Regeneron Healthcare Solutions, Inc. | 5 | $160 |
| Merck | 7 | $159 |
| AstraZeneca(2 entities) | 6 | $142 |
| Astellas Pharma US Inc | 3 | $120 |
| Seagen Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $70 |
| AVEO Pharmaceuticals, Inc. | 3 | $65 |
| ADC Therapeutics America, Inc. | 3 | $61 |
| EMD Serono, Inc. | 2 | $54 |
| Pharmacosmos Therapeutics Inc. | 2 | $49 |
| Exelixis Inc. | 2 | $49 |
| Genmab U.S., Inc. | 3 | $44 |
| Eisai Inc. | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Bayer | 2 | $30 |
| Dendreon Pharmaceuticals LLC | 1 | $28 |
| Genentech USA, Inc. | 1 | $25 |
| Sobi, Inc | 1 | $25 |
| Boehringer Ingelheim | 1 | $25 |
| Taiho Oncology, Inc. | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $21 |
| Pfizer | 1 | $21 |
| Pharmaessentia USA Corporation | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Invivyd Inc | 1 | $19 |
| Caris MPI, Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $16 |
How this compares
$2,588 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 63 | $542 |
| Acyclovir | 22 | $339 |
| Prochlorperazine Maleate | 16 | $173 |
| Prednisone | 18 | $84 |
| Ondansetron Hcl | 17 | $69 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $32 |
Paid to pharmacies, not to this prescriber.
Other family in Meadville
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.